Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Back

ESC Premium Access

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Session: New treatment studies in heart failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor H. Kihara (Asahikawa, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Hajime Kihara

Kihara Cardiovascular Clinic, Asahikawa (Japan)

0 follower

8 more presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Speaker: Doctor J. Cheng (Taipei, TW)

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)

Access

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)

Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Speaker: Doctor D. Pascual Figal (Murcia, ES)

Access the full session

New treatment studies in heart failure

Speakers: Doctor H. Kihara, Doctor D. Fouassier, Doctor J. Cheng, Associate Professor A. Kalogeropoulos, Mr M. Godet...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources